The Defense Threat Reduction Agency’s Research and Development (RD) Directorate will host a virtual Industry Day for the CWMD IDIQ. The CWMD IDIQ is a competitive multiple award IDIQ with a scope that supports a wide breadth of the RD Directorate’s requirements. The ordering period for the current contract will expire in December 2023.
The A&AS services will support across the chemical, biological, radiological, nuclear and high-yield explosives (CBRNE) spectrum and in the countering weapons of mass destruction (CWMD), countering improvised threats (CIT) and countering improvised threat networks (CTN) mission domains. The contracting officer has determined that market research supports a total small business set aside for the Programmatic (PMO) A&AS Follow On contract.
The overall scope of the work is to acquire subject matter expertise to provide fully integrated AAS support to the SI Directorate in the daily performance and execution of its mission to Combat Weapons of Mass Destruction (CWMD) as assigned by the Department of Defense. These services are considered non-commercial in nature.
The overall scope of the work is to acquire subject matter expertise to provide fully integrated AAS support to the SI Directorate in the daily performance and execution of its mission to Combat Weapons of Mass Destruction (CWMD) as assigned by the Department of Defense. These services are considered non-commercial in nature.
21st Century (HSPD-10) and in 2007 in Medical Countermeasures against Weapons of Mass Destruction (HSPD-18).
21st Century (HSPD-10) and in 2007 in Medical Countermeasures against Weapons of Mass Destruction (HSPD-18).
Response and recovery were identified as key elements of national defense in the National Strategy to Combat Weapons of Mass Destruction issued in 2002 (National Security Presidential Directive-17/Homeland Security Presidential Directive-4, NSPD-17/HSPD-4) and in the National Military Strategy to Combat Weapons of Mass Destruction (NMS-CWMD), released in 2006. This procurement is also aligned with the Project Bioshield Act of 2004 (Pub. L.
